Anne-Sophie Chalandon | Head of Global Public Affairs, Rare Diseases and CGT Policies
Sanofi

Anne-Sophie Chalandon, Head of Global Public Affairs, Rare Diseases and CGT Policies, Sanofi

Appearances:



Pre-Congress Workshops - Monday 27th October @ 14:00

The Rare Disease Action Plan – Where are we now?

Rare diseases pose unique challenges to healthcare systems worldwide due to their low prevalence and complex treatment requirements. Traditional financing mechanisms often fail to adequately address the needs of patients with rare diseases, leading to disparities in access to treatment and care. Last June, RDI (Rare Diseases International) launched a campaign for a World Health Assembly (WHA) Resolution on Rare Diseases in 2025. RDI is launching a campaign for a World Health Assembly (WHA) Resolution on Rare Diseases in 2025.

Day 2 - Wednesday 29 October @ 16:30

Keynote Panel: In what way can we mobilise, enable and leverage international policies around the world for PLWRDs?

Invited: Dr Mohamed Hassany, Assistant Minister for Public Health Initiative, Ministry of Health Egypt

last published: 19/Jun/25 12:15 GMT

back to speakers

Get involved at World Orphan Drug Congress Europe 2025

 

 

TO SPONSOR


Steph Scanlon

Steph.Scanlon@terrapinn.com

 

TO SPEAK


Abdu Kauroo
Abdu.Kauroo@terrapinn.com

 

MARKETING & PRESS


Jasper Cameron

Jasper.Cameron@terrapinn.com

 

Stay Up-to-Date

Join our mailing list to receive exclusive content and offers.

By submitting, you agree to receive email communications from Terrapinn, including upcoming promotions and discounted tickets and news.